Skip to main content

Investors Are Moving Back Into Resurgent Biotech ETFs

After stumbling through much of 2019, biotechnology ETFs are finding their grooves in the fourth quarter. Since the start of the current quarter, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB) is higher by more than 16% while the SPDR S&P Biotech ETF (NYSEArca: XBI) is up 17.40%. IBB...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.